... vaccines]," Larry Schlesinger, MD president and chief executive officer of the Texas Biomedical Research Institute in San Antonio, told Healthline.
News
- This Is Why Half of People Have Stronger Vaccine Side Effects, CDC Says
- HOU Talk: How Houston can be the next hub for oncology innovation
... and biotech innovators have to make the city a hub for cancer innovation. ... encompassing Houston, Dallas-Fort Worth, Austin, and San Antonio.
- GMP Grade Cytokines Market to Witness Robust Expansion by 2027 with Top Key players like ...
... GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological, Creative Bioarray, Akron Biotech, Almog ... 1604 W San Antonio,.
- New Study Presents Evidence of Effectiveness and Safety Of Oleandrin and Phoenix ...
The Journal of Biomedicine & Pharmacotherapy is an open access, ... Phoenix Biotechnology, Inc., headquartered in San Antonio, has been exploring ...
- UK variant set to become dominant variant in Texas, US by end of March
... and will in a few weeks be the predominant variant of concern,” said Dr. Ilya Finkelstein, Associate Professor of Molecular Biosciences at UT Austin.